DeuteRx, LLC
23Patents
23Active
23Granted
52Portfolio score
Filing activity: Aug 22, 2008 → May 1, 2024 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8524780B2 | Deuterium-enriched bupropion | Chemistry; Metallurgy | 110 | Active |
| US9732031B2 | Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion | Chemistry; Metallurgy | 109 | Active |
| US9090585B2 | 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds | Chemistry; Metallurgy | 23 | Active |
| US8722710B2 | Deuterium-enriched pioglitazone | Chemistry; Metallurgy | 19 | Active |
| US8969581B2 | 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same | Chemistry; Metallurgy | 16 | Active |
| US9416117B2 | 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same | Chemistry; Metallurgy | 11 | Active |
| US9809603B1 | Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same | Chemistry; Metallurgy | 11 | Active |
| US9833445B2 | 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same | Chemistry; Metallurgy | 10 | Active |
| US9290475B2 | 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 9 | Active |
| US9540340B2 | 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 8 | Active |
| US9925175B2 | Deuterium-enriched pioglitazone | Chemistry; Metallurgy | 7 | Active |
| US10188639B2 | Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone | Human Necessities | 3 | Active |
| US10189858B2 | Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same | Chemistry; Metallurgy | 3 | Active |
| US8735454B2 | Deuterium-enriched bupropion | Chemistry; Metallurgy | 2 | Active |
| US11535603B1 | Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same | Human Necessities | 2 | Active |
| US10202316B2 | 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 2 | Active |
| US9913845B2 | 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 1 | Active |
| US8669275B2 | Deuterium-enriched donepezil | Human Necessities | 1 | Active |
| US10555946B2 | 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US8669268B2 | Deuterium-enriched prasugrel | Chemistry; Metallurgy | 0 | Active |
| US11040925B2 | 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11491156B2 | 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US12180137B1 | Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.